Literature DB >> 30014526

Structural signature of SCA3: From presymptomatic to late disease stages.

Thiago Junqueira Ribeiro Rezende1, Jean Levi Ribeiro de Paiva1, Alberto Rolim Muro Martinez1, Iscia Lopes-Cendes2, José Luiz Pedroso3, Orlando Graziani Povoas Barsottini3, Fernando Cendes1, Marcondes C França1.   

Abstract

OBJECTIVE: Machado-Joseph disease (SCA3/MJD) is the most frequent spinocerebellar ataxia worldwide and characterized by brainstem, basal ganglia, and cerebellar damage. However, little is known about the natural history of the disease. This motivated us to determine the extension and progression of central nervous system involvement in SCA3/MJD using multimodal magnetic resonance imaging (MRI)-based analyses in a large cohort of patients (n = 79) and presymptomatic subjects (n = 12).
METHODS: All subjects underwent MRI in a 3T device to assess gray and white matter. To evaluate the cerebral and cerebellar cortices, we used measures from FreeSurfer and SUIT. T1-multiatlas assessed deep gray matter. Diffusion tensor imaging multiatlas was used to investigate cerebral white matter (WM) and SpineSeg to assess the cervical spinal cord.
RESULTS: There was widespread WM and cerebellar damage, in contrast to the restricted motor cortex involvement when all patients are compared to age- and sex-matched controls. Presymtomatic patients showed WM microstructural abnormalities mainly in the cerebellar and cerebral peduncles and volumetric reduction of midbrain, spinal cord, and substantia nigra. To assess the disease progression, we divided patients into four subgroups defined by time from ataxia onset. There was a clear pattern of evolving structural compromise, starting in infratentorial structures and progressing up to the cerebral cortex.
CONCLUSION: Structural damage in SCA3/MJD begins in the spinal cord, cerebellar peduncles, as well as substantia nigra and progresses to cerebral areas in the long term. These structural differences reveal some insights into the pathogenesis of SCA3/MJD and suggest a staging scheme to map the progression of the disease. Ann Neurol 2018;84:401-408.
© 2018 American Neurological Association.

Entities:  

Mesh:

Year:  2018        PMID: 30014526     DOI: 10.1002/ana.25297

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  25 in total

1.  In Vivo Molecular Signatures of Cerebellar Pathology in Spinocerebellar Ataxia Type 3.

Authors:  Maria do Carmo Costa; Maria Radzwion; Hayley S McLoughlin; Naila S Ashraf; Svetlana Fischer; Vikram G Shakkottai; Patrícia Maciel; Henry L Paulson; Gülin Öz
Journal:  Mov Disord       Date:  2020-07-04       Impact factor: 10.338

Review 2.  Deafness and Vestibulopathy in Cerebellar Diseases: a Practical Approach.

Authors:  Orlando G Barsottini; José Luiz Pedroso; Carlos Roberto Martins; Marcondes Cavalcante França; Pedro Mangabeira Albernaz
Journal:  Cerebellum       Date:  2019-12       Impact factor: 3.847

3.  Magnetic Resonance Imaging and Its Clinical Correlation in Spinocerebellar Ataxia Type 3: A Systematic Review.

Authors:  Kah Hui Yap; Hanani Abdul Manan; Noorazrul Yahya; Shahrul Azmin; Shahizon Azura Mohamed Mukari; Norlinah Mohamed Ibrahim
Journal:  Front Neurosci       Date:  2022-06-10       Impact factor: 5.152

4.  Brain structural abnormalities in the preclinical stage of Machado-Joseph disease/spinocerebellar ataxia type 3 (MJD/SCA3): evaluation by MRI morphometry, diffusion tensor imaging and neurite orientation dispersion and density imaging.

Authors:  Mengcheng Li; Xinyuan Chen; Hao-Ling Xu; Ziqiang Huang; Naping Chen; Yuqing Tu; Shirui Gan; Jianping Hu
Journal:  J Neurol       Date:  2021-11-16       Impact factor: 6.682

5.  Corticospinal tract involvement in spinocerebellar ataxia type 3: a diffusion tensor imaging study.

Authors:  Bruno Shigueo Yonekura Inada; Thiago Junqueira Ribeiro Rezende; Fernando Vieira Pereira; Lucas Ávila Lessa Garcia; Antônio José da Rocha; Pedro Braga Neto; Orlando Graziani Povoas Barsottini; Marcondes Cavalcante França; José Luiz Pedroso
Journal:  Neuroradiology       Date:  2020-09-02       Impact factor: 2.804

Review 6.  Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy development.

Authors:  Meng-Ling Chen; Chih-Chun Lin; Liana S Rosenthal; Puneet Opal; Sheng-Han Kuo
Journal:  J Neurol Sci       Date:  2021-04-01       Impact factor: 3.181

7.  Impaired Oligodendrocyte Maturation Is an Early Feature in SCA3 Disease Pathogenesis.

Authors:  Kristen H Schuster; Annie J Zalon; Hongjiu Zhang; Danielle M DiFranco; Nicholas R Stec; Zaid Haque; Kate G Blumenstein; Amanda M Pierce; Yuanfang Guan; Henry L Paulson; Hayley S McLoughlin
Journal:  J Neurosci       Date:  2022-01-18       Impact factor: 6.709

8.  Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel-Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3.

Authors:  David D Bushart; Annie J Zalon; Hongjiu Zhang; Logan M Morrison; Yuanfang Guan; Henry L Paulson; Vikram G Shakkottai; Hayley S McLoughlin
Journal:  Cerebellum       Date:  2021-02       Impact factor: 3.847

9.  Quality of Life since Pre-Ataxic Phases of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.

Authors:  Gabriela Bolzan; Vanessa Bielefeldt Leotti; Camila Maria de Oliveira; Gabriela Ecco; Amanda Henz Cappelli; Anastacia Guimarães Rocha; Nathalia Kersting; Mariana Rieck; Lucas Schenatto de Sena; Ana Carolina Martins; Maria-Luiza Saraiva-Pereira; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2021-07-06       Impact factor: 3.847

10.  Broad Influence of Mutant Ataxin-3 on the Proteome of the Adult Brain, Young Neurons, and Axons Reveals Central Molecular Processes and Biomarkers in SCA3/MJD Using Knock-In Mouse Model.

Authors:  Kalina Wiatr; Łukasz Marczak; Jean-Baptiste Pérot; Emmanuel Brouillet; Julien Flament; Maciej Figiel
Journal:  Front Mol Neurosci       Date:  2021-06-17       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.